NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+67.03%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.11B
AUM Growth
+$2.11B
Cap. Flow
+$356M
Cap. Flow %
16.84%
Top 10 Hldgs %
69.55%
Holding
49
New
3
Increased
4
Reduced
1
Closed
2

Top Buys

1
SPT icon
Sprout Social
SPT
$145M
2
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
$145M
3
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
$57.4M
4
MEIP icon
MEI Pharma
MEIP
$6.97M
5
ARDX icon
Ardelyx
ARDX
$6M

Top Sells

1
KA
Kineta, Inc. Common Stock
KA
$4.7M
2
AKAO
Achaogen, Inc.
AKAO
$63K

Sector Composition

1 Healthcare 84.91%
2 Technology 11.98%
3 Industrials 0.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CSBR icon
26
Champions Oncology
CSBR
$95.8M
$13M 0.62%
1,562,500
– –
XENE icon
27
Xenon Pharmaceuticals
XENE
$2.99B
$13M 0.62%
992,107
+389,444
+65% +$5.11M
TPST icon
28
Tempest Therapeutics
TPST
$46.6M
$11.9M 0.56%
9,060
– –
SYBX icon
29
Synlogic
SYBX
$17.4M
$10.9M 0.52%
281,961
– –
LQDA icon
30
Liquidia Corp
LQDA
$2.52B
$10.6M 0.5%
2,486,062
– –
BE icon
31
Bloom Energy
BE
$12.3B
$9.96M 0.47%
1,333,333
– –
LXRX icon
32
Lexicon Pharmaceuticals
LXRX
$392M
$9.89M 0.47%
2,382,286
– –
SBBP
33
DELISTED
Strongbridge Biopharma plc.
SBBP
$8.67M 0.41%
4,141,308
– –
DZSI
34
DELISTED
DZS Inc. Common Stock
DZSI
$8.47M 0.4%
956,255
– –
VRNA
35
Verona Pharma
VRNA
$9.18B
$7.01M 0.33%
1,219,674
– –
RIGL icon
36
Rigel Pharmaceuticals
RIGL
$710M
$6.94M 0.33%
324,315
– –
SURF
37
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$6.23M 0.29%
3,315,149
– –
CTIC
38
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5.83M 0.28%
3,750,000
– –
PHXM
39
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$4.61M 0.22%
62,500
– –
XFOR icon
40
X4 Pharmaceuticals
XFOR
$70M
$3.57M 0.17%
11,111
– –
TRVN
41
DELISTED
Trevena, Inc.
TRVN
$3.21M 0.15%
6,099
– –
TRIL
42
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.16M 0.1%
2,100,000
– –
RGLS
43
DELISTED
Regulus Therapeutics
RGLS
$1.83M 0.09%
205,246
– –
TCON
44
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$811K 0.04%
17,336
– –
AKTX
45
Akari Therapeutics
AKTX
$21.4M
$791K 0.04%
22,608
– –
VIRX
46
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$438K 0.02%
37,094
– –
ELGX
47
DELISTED
Endologix Inc
ELGX
$393K 0.02%
249,021
– –
KA
48
DELISTED
Kineta, Inc. Common Stock
KA
– –
-39,691
Closed -$4.7M
AKAO
49
DELISTED
Achaogen, Inc.
AKAO
– –
-5,215,128
Closed -$63K
1
2